Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04196868
PHASE2

Methotrexate and Metformin in Rheumatoid Arthritis Patients

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

Methotrexate (MTX) is the anchor drug for patients with rheumatoid arthritis (RA). Despite its marked efficacy and acceptable side effect profile, about 1/3 of patients failed to reach RA remission. Metformin is the first-line therapy for type 2 diabetes. Its antioxidative and anti-inflammatory properties make it a good candidate for the treatment of inflammatory diseases such as rheumatoid arthritis.

Official title: Randomized Placebo-controlled Trial Comparing Methotrexate vs. Methotrexate/Metformin Association in Rheumatoid Arthritis Patients

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

128

Start Date

2020-12-03

Completion Date

2026-06

Last Updated

2026-02-03

Healthy Volunteers

No

Interventions

DRUG

Metformin treatment

1500 mg once a day, per os, during six months

OTHER

Placebo

per os, during six months

DRUG

Methotrexate treatment

per os

Locations (12)

CH de la Côte Basque - service de rhumatologie

Bayonne, France

CHU de Bordeaux - service de rhumatologie

Bordeaux, France

CHU de Brest - service de rhumatologie

Brest, France

CH de Cahors - service de rhumatologie

Cahors, France

Clinique de l'Infirmerie protestante de Lyon - service de rhumatologie

Caluire-et-Cuire, France

CHD de Vendée - service de rhumatologie

La Roche-sur-Yon, France

CH du Mans - service de rhumatologie

Le Mans, France

CH de Libourne - service de rhumatologie

Libourne, France

CHU de Montpellier - service de rhumatologie

Montpellier, France

CHR Orléans la Source - service de rhumatologie

Orléans, France

CH de Pau - service de rhumatologie

Pau, France

CHU de Toulouse - service de rhumatolgie

Toulouse, France